| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.4M | -49.9% | -26.1% |
| Cost of Revenue | $5.9M | -46.2% | -21.0% |
| Gross Profit | $1.4M | -61.1% | -41.8% |
| R&D Expense | $330K | +0.1% | +68.3% |
| SG&A Expense | $750K | +14.5% | +25.0% |
| Operating Income | -$1.3M | -232.3% | -390.9% |
| Pre-tax Income | -$1.3M | -236.5% | -405.4% |
| Income Tax | -$464K | -245.3% | -500.2% |
| Net Income | -$820K | -232.0% | -369.3% |
| EPS (Basic) | -$0.04 | -233.3% | -300.0% |
| EPS (Diluted) | -$0.04 | -233.3% | -300.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $858K | -27.1% | — |
| Accounts Receivable | $168K | +46.2% | — |
| Inventory | $7.4M | -5.5% | — |
| Current Assets | $11.2M | -3.3% | — |
| Total Assets | $14.3M | -4.2% | — |
| Current Liabilities | $10.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | — | — |
| Capital Expenditures | $393K | — | — |
| Investing Cash Flow | -$393K | — | — |
| Financing Cash Flow | -$162K | — | — |
| Free Cash Flow | -$3.7M | — | — |
| +4.3% |
| — |
| Total Liabilities | $10.7M | +1.8% | — |
| Stockholders' Equity | $3.6M | -18.7% | +12.8% |